Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.

FRAZER, Pa., Dec. 17, 2010 /PRNewswire via COMTEX/ -- Cephalon, Inc. (Nasdaq: CEPH) is sad to announce today that its founder, Chairman and Chief Executive Officer, Frank Baldino, Jr., Ph.D. passed away Thursday evening, December 16, 2010. A pioneer in the biotechnology industry, he was an inspirational leader who will be sorely missed. The Cephalon organization mourns his passing and extends its sympathies to the entire Baldino family.

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.